Alcon shares seen rising after outlook hike
BUZZ-Alcon shares seen rising after outlook hike ** Shares of AlconALCC.S are seen up 5.1% in Julius-Baer pre-market indications after the Swiss-American eye-care company raised its full-year earnings forecasts late on Monday
** Alcon expects its core operating profit margin to grow by 90-190 basis points in 2026, instead of the 70-170 bps rise previously guided for
** The company also reported a 7% year-on-year increase in Q2 sales to $2.782 billion
** "Alcon demonstrates positive strategic direction," Vontobel analysts said, pointing to improving margins and the recently announced development collaboration with RxSight
** Alcon is the top gainer in Julius-Baer pre-market indications of the Swiss main index .SSMI
** Its New York-listed shares ALC.N closed 2.5% higher on Monday
(Reporting by Simon Ferdinand Eibach)
Recent news on Alcon AG
See all newsBrief: Alcon Acquires Neurotech And Encelto, The Only FDA-Approved Treatment For Mactel Type 2
Brief: Alcon Acquires Neurotech And Encelto, The Only FDA-Approved Treatment For Mactel Type 2
Swiss stocks - Factors to watch on October 19
Brief: FDA Approves Alcon’S BRYTL Eye Drops
Advisory: Alert incorrectly tagged to Omega Interactive Technologies withdrawn